Diamond J. The double puzzle of diabetes[J]. Nature, 2003,423(6940):599-602.
[2]
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030[J]. Diabetes Care, 2004,27(10):1047-1053.
[3]
Zimmet P Z, Alberti K G M M, Shaw J. Global and societal implications of the diabetes epidemic[J]. Nature, 2001,414(6865):782-787.
[4]
World Health Organization (WHO). Disease action now booklet[EB/OL]. [2015-02-06].http://www.who.int/diabetes/actionnow/en/.
[5]
Humljan J, Kotnik M, Contreras-Martel C, et al. Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme[J]. Journal of Medicinal Chemistry, 2008,51(23):7486-7494.
[6]
Holloway M K, Hunt P, McGaughey G B. Structure and modeling in the design of β-and γ-secretase inhibitors[J]. Drug Development Research, 2009,70(2):70-93.
[7]
Lee J, Song L, Terracina G, et al. Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes[J]. Biochemistry, 2011,50(22):4973-4980.
[8]
Silvestri R. Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer\'s disease[J]. Medicinal Research Reviews, 2009,29(2):295-338.
[9]
MacMillan K S, Naidoo J, Liang J, et al. Development of proneurogenic, neuroprotective small molecules[J]. Journal of the American Chemical Society, 2011,133(5):1428-1437.
[10]
Chen X, Yang Y C, Ma B, et al. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold[J]. European Journal of Medicinal Chemistry, 2011,46 (5):1536-1544.
[11]
Chen X, Zhang S, Yang Y, et al. 1,2-benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase[J]. Bioorganic & Medicinal Chemistry, 2011,19(23):7262-7269.
[12]
Chen X, Zhu C J, Guo F, et al. Acetic acid derivatives of 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide as a novel class of potent aldose reductase inhibitors[J]. Journal of Medicinal Chemistry, 2010,53(23):8330-8344.
[13]
Yang Y, Zhang S, Wu B, et al. An efficient synthesis of quinoxalinone derivatives as potent aldose reductase inhibitors[J]. Chem med chem, 2012,7(5):823-835.
[14]
Zhang S, Chen X, Parveen S, et al. Effect of C7 modifications on benzothiadiazine-1,1-dioxidederivatives on their inhibitory activity and selectivity toward aldose reductase[J]. Chem med chem, 2013,8(4):603-613.
